Correlation Between GlaxoSmithKline PLC and Evaluator Moderate
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Evaluator Moderate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Evaluator Moderate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Evaluator Moderate Rms, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Evaluator Moderate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Evaluator Moderate. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Evaluator Moderate.
Diversification Opportunities for GlaxoSmithKline PLC and Evaluator Moderate
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and Evaluator is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Evaluator Moderate Rms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaluator Moderate Rms and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Evaluator Moderate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaluator Moderate Rms has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Evaluator Moderate go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Evaluator Moderate
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Evaluator Moderate. In addition to that, GlaxoSmithKline PLC is 3.19 times more volatile than Evaluator Moderate Rms. It trades about -0.33 of its total potential returns per unit of risk. Evaluator Moderate Rms is currently generating about 0.12 per unit of volatility. If you would invest 1,092 in Evaluator Moderate Rms on August 27, 2024 and sell it today you would earn a total of 12.00 from holding Evaluator Moderate Rms or generate 1.1% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Evaluator Moderate Rms
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Evaluator Moderate Rms |
GlaxoSmithKline PLC and Evaluator Moderate Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Evaluator Moderate
The main advantage of trading using opposite GlaxoSmithKline PLC and Evaluator Moderate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Evaluator Moderate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaluator Moderate will offset losses from the drop in Evaluator Moderate's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Evaluator Moderate vs. Eic Value Fund | Evaluator Moderate vs. Balanced Fund Investor | Evaluator Moderate vs. L Abbett Fundamental | Evaluator Moderate vs. Ips Strategic Capital |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |